Researchers analyzed HIV patients—one of the most medically vulnerable populations you can study—and found that cannabis use was not associated with heart abnormalities. Let me repeat that for the people in the back: not associated with heart abnormalities.
Take cannabis, for example—my favorite barometer for societal sanity. We went from "this will literally destroy your brain and turn you into a violent criminal" to "okay maybe it's medicine" to "actually it's legal in half the states" to "wait no we're banning hemp THC and maybe repealing legalization entirely" to "Schedule III but only for Big Pharma" all within a couple of decades. And we're supposed to pretend this makes sense?
Furthermore, Schedule III could mean that independent researchers—not just pharma shills—might finally get a seat at the table. Universities won't have to fear losing their funding just for touching the plant. We might see a new wave of "less biased" research that explores the nuances of the entourage effect or minor cannabinoids like THCV or CBG, rather than just focusing on how much "reefer madness" can be induced in a lab rat.
Well, folks, we made it through another year in the wildest timeline. 2025 was a rollercoaster ride through cannabis policy chaos, and I've got the whiplash to prove it. As I sit here reflecting on the year that was, I'm reminded that trying to make sense of cannabis policy in America is like trying to nail Jell-O to a wall while riding a unicycle backwards. It's messy, it's unpredictable, and you're probably going to fall on your ass.
Have you scromited yet? No? Well, buckle up, because that's the latest buzzword the propaganda machine wants you to associate with cannabis. And if you haven't heard of it yet, don't worry—you will. They're making sure of that.
The Greench hated Dankmas! The whole Dankmas season! Now, please don't ask why. There were plenty of reasons. It could be his head wasn't screwed on quite right. It could be, perhaps, that his wallet was tight. But I think that the most likely reason of all May have been that his profit margins were two sizes too small.
Trump’s executive order reclassifying weed as a Schedule III substance is breakthrough news for patients, researchers, and the cannabis industry as a whole. It doesn’t legalize weed nor does it legalize recreational use, but by removing federal barriers to research, it helps us progress so much faster.
Just when you thought the cannabis legalization train was unstoppable, reality is about to slap you in the face. According to a recent Vice article, several states are considering repealing their legal cannabis markets in 2026. That's right—not just pausing expansion, not just adding more regulations, but actually rolling back legalization entirely and returning to prohibition.
So Trump is allegedly about to sign an executive order rescheduling marijuana to Schedule III, and we're supposed to celebrate this as some kind of victory for cannabis reform. Let me be crystal clear: this isn't a win for anyone except Big Pharma and the massive cannabis corporations that have been lobbying for this exact outcome for years.
Cannabis just took a major blow. After years of operating in a legal gray area that allowed hemp-derived THC products to flourish, Congress decided to slam the door shut with a ban set to take effect in 2026. But here's the kicker: this ban might be one of the most spectacularly unenforceable pieces of legislation in recent history. And in trying to "protect the children" with this ban, the government is about to hand a $32 billion industry directly to the black market and the cartels they claim to be fighting.
